Clinicopathologic Conference, Insulinoma
NEJM 387:356-365, Case 23-2022, 2022
Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Adult Attention Deficit - Hyperactivity Disorder
NEJM 369:1935-1944, Volkow, N.D. & Swanson, J.M., 2013
Development of a Suspicion Index to Aid Diagnosis of Niemann-Pick Disease Type C
Neurol 78:1560-1567,1546, Wijburg, F.A.,et al, 2012
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Autism
Lancet 374:1627-1638, Levy,S.,et al, 2009
Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008
Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008
Whipples Disease
NEJM 356:55-66, Fenollar,F.,et al, 2007
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Dementia with Lewy Bodies
Lancet 362:1689-1690, Wilcock,G.K., 2003
Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder
Pediatrics 105:1158-1170, Homer,C.J.,et al, 2000
Using the Berlin Questionnaire to Identify Patients at Risk for the Sleep Apnea Syndrome
Ann Int Med 131:485-491,535, Netzer,N.C.,et al, 1999
Attention-Deficit Hyperactivity Disorder and Hyperkinetic Disorder
Lancet 351:429-433, 3871998., Swanson,J.M.,et al, 1998
Natural History of Progressive Supranuclear Palsy & Clin Predictors of Survival:A Clinicopath Study
JNNP 61:615-620, Litvan,I.,et al, 1996
Diagnostic Guidelines in Central Nervous System Whipple's Disease
Ann Neurol 40:561-568, Louis,E.D.,et al, 1996
Psychosis as the Initial Manifestation of Adult-Onset Niemann-Pick Disease Type C
Neurol 45:1739-1743, Shulman,L.M.,et al, 1995